- Report
- January 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- April 2024
- 196 Pages
Global
From €5414EUR$5,600USD£4,650GBP
- Report
- February 2024
- 175 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Report
- August 2023
- 118 Pages
Global
From €7251EUR$7,500USD£6,228GBP
- Report
- November 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,069GBP
- Report
- September 2021
- 90 Pages
Global
From €696EUR$720USD£598GBP
€870EUR$900USD£747GBP
- Report
- March 2022
- 300 Pages
Global
From €4834EUR$5,000USD£4,152GBP
- Report
- August 2022
- 135 Pages
Global
From €4592EUR$4,750USD£3,945GBP
- Report
- May 2020
- 200 Pages
Global
From €6719EUR$6,950USD£5,771GBP
- Report
- August 2022
- 117 Pages
Global
From €4351EUR$4,500USD£3,737GBP
- Drug Pipelines
- February 2018
- 373 Pages
Global
From €21269EUR$22,000USD£18,269GBP
- Drug Pipelines
- August 2020
- 56 Pages
Global
From €1934EUR$2,000USD£1,661GBP
- Report
- January 2024
- 89 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- January 2024
- 86 Pages
Global
From €3500EUR$3,878USD£3,112GBP
- Report
- April 2024
- 50 Pages
Global
From €2562EUR$2,650USD£2,201GBP
- Report
- April 2024
- 50 Pages
Global
From €2562EUR$2,650USD£2,201GBP
- Report
- March 2022
Global
From €4689EUR$4,850USD£4,028GBP
- Report
- March 2020
Japan, United States, ... Japan, United States, Europe
From €1402EUR$1,450USD£1,204GBP
Warfarin is a cardiovascular drug used to prevent and treat blood clots. It is an anticoagulant, meaning it helps to prevent the formation of clots in the blood vessels. Warfarin is used to treat and prevent deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to reduce the risk of stroke in people with atrial fibrillation. Warfarin is available in both generic and brand-name forms.
The Warfarin market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the major players in the market include Pfizer, GlaxoSmithKline, Sanofi, Bristol-Myers Squibb, and Merck. Other companies include Teva Pharmaceuticals, Mylan, and Novartis. Show Less Read more